regimen
Patients, over 80% of       whom were on a concurrent inhaled corticosteroid regimen, were treated for 4       weeks with either inhaled salmeterol xinafoate 42 microgram twice daily       administered by means of a metered-dose inhaler or oral zafirlukast 20 mg twice       daily.
Patients, over 80% of       whom were on a concurrent inhaled  @OBJECT$  @PREDICAT$  @SUBJECT$ , were treated for 4       weeks with either inhaled salmeterol xinafoate 42 microgram twice daily       administered by means of a metered-dose inhaler or oral zafirlukast 20 mg twice       daily.